Patents by Inventor Gad Galili

Gad Galili has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9909135
    Abstract: The present invention provides transgenic plants comprising 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate (DAHP) Synthase that is insensitive to feedback inhibition, particularly to feedback inhibition by phenylalanine, producing increased amounts of the Shikimate pathway primary and secondary metabolites, including aromatic amino acids compared to corresponding non-transgenic plants.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: March 6, 2018
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Gad Galili, Asaph Aharoni, Vered Tzin, Sergey Malitsky, Ilana Rogachev
  • Publication number: 20130111631
    Abstract: The present invention provides transgenic plants comprising 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate (DAHP) Synthase that is insensitive to feedback inhibition, particularly to feedback inhibition by phenylalanine, producing increased amounts of the Shikimate pathway primary and secondary metabolites, including aromatic amino acids compared to corresponding non-transgenic plants.
    Type: Application
    Filed: July 6, 2011
    Publication date: May 2, 2013
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Gad Galili, Asaph Aharoni, Vered Tzin, Sergey Malitsky, Ilana Rogachev
  • Publication number: 20100281567
    Abstract: The present invention relates to means and methods for altering the level of at least one of the aromatic amino acids phenylalanine, tryptophan and tyrosine and secondary metabolites in plants. Particularly, the present invention discloses transgenic plants comprising polynucleotides encoding chorismate mutase and prephenate dehydratase enzymes, having elevated amounts of at least one of phenylalanine, tyrosine and modified amount of at least one secondary metabolite derived therefrom, and reduced amount of tryptophan and at least one secondary metabolite derived from tryptophan.
    Type: Application
    Filed: December 3, 2008
    Publication date: November 4, 2010
    Inventors: Gad Galili, Vered Tzin, Asaph Aharoni, Sergey Malitsky
  • Patent number: 6677506
    Abstract: An isolated DNA molecule is provided coding for a polypeptide of the 11-12 transmembrane domain transporter family having a Mg2+/H+ or Zn2+/H+ exchange activity, herein designated MHX. The genomic MHX DNA was isolated from Arabidopsis thaliana cv. C-24. Transgenic plants transformed with said DNA and expressing MHX are shown to have a lower content of sodium as compared with corresponding wild-type plants or a higher dry matter weight upon growth in calcium-rich media as compared with corresponding wild-type plants. These transgenic plants are tolerant to stress conditions, particularly high salinity and calcium-rich media, e.g. saline and calcareous soils.
    Type: Grant
    Filed: November 24, 2000
    Date of Patent: January 13, 2004
    Assignees: Yeda Research and Development Co. Ltd., The University of Texas System
    Inventors: Gad Galili, Orit Shaul, Dirk Inze, Marc Van Montagu, Donald W. Hilgemann
  • Patent number: 5367110
    Abstract: A chimeric gene construct comprising a DNA sequence encoding an enzyme having aspartate kinase (AK) activity is provided, which is capable of expression in plant cells with subsequent increased production of threonine. Transgenic plants containing in their cells said chimeric gene overproduce threonine and transgenic plants containing in their cells said chimeric gene and a second chimeric gene comprising a DNA sequence coding for an enzyme having dihydrodipicolinate synthase (DHPS) activity, overproduce both threonine and lysine. The transgenic plants are resistant to lysine and threonine, to derivatives thereof and to selective inhibitors of the plant enzymes DHPS or AK, and thus these compounds may be used as selective herbicides in locus where the transgenic plants are cultivated.
    Type: Grant
    Filed: November 13, 1991
    Date of Patent: November 22, 1994
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Gad Galili, Orit Shaul, Avihai Perl
  • Patent number: 4886878
    Abstract: Modified 19kd and 22kd zeins containing lysine are provided. Lysine additions are made by modifying structural genes which encode 19kd and 22kd pre-zeins. Modified zeins produced from the modified structural gene templates are found to retain important properties of unmodified zeins, having similar molecular weights, having the ability to form protein bodies within the rough endoplasmic reticulum of a host cell and being soluble in alcohol.
    Type: Grant
    Filed: November 22, 1988
    Date of Patent: December 12, 1989
    Assignees: Lubrizol Genetics, Inc., Purdue Research Foundation, Inc.
    Inventors: Brian Larkins, Richard E. Cuellar, John C. Wallace, Gad Galili